A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury

Journal of Head Trauma Rehabilitation

Volumn 23, Issue 1, 2008, Pages 52-63

  Jha, Amitabh ^a,b,c   Weintraub, Alan ^a   Allshouse, Amanda ^b   Morey, Clare ^a   Cusick, Chris ^a   Kittelson, John ^a,b   Harrison Felix, Cynthia ^a,b   Whiteneck, Gale ^a,b   Gerber, Don ^a  

^a Craig Hospital

^b UNIVERSITY OF COLORADO   (United States)

^c CRAIG HOSPITAL   (United States)

Author keywords

Brain injury; Fatigue; Modafinil; Randomized clinical trial

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAYTIME SOMNOLENCE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSTHYMIA; FATIGUE; FEMALE; HEADACHE; HUMAN; INJURY SEVERITY; INSOMNIA; MALE; NAUSEA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; TRAUMATIC BRAIN INJURY; TREMOR; VERBAL MEMORY; VISUAL MEMORY;

ADULT; BENZHYDRYL COMPOUNDS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; SLEEP DISORDERS, CIRCADIAN RHYTHM; TREATMENT OUTCOME;

EID: 38549090810     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HTR.0000308721.77911.ea     Document Type: Article

References (78)

1. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14:602-615.
2. Walker EA, Katon WJ, Jemelka RP. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med. 1993;8:436-440.
3. Kjerulff KH, Langenberg PW. A comparison of alternative ways of measuring fatigue among patients having hysterectomy. Med Care. 1995;33:156-163.
4. Whiteneck G, Brooks CA, Mellick D, Harrison-Felix C, Terrill MS, Noble K. Population-based estimates of outcomes after hospitalization for traumatic brain injury in Colorado. Arch Phys Med Rehabil. 2004;85(4, suppl 2):73-81.
5. Warden DL, Salazar AM, Martin EM, Schwab KA, Coyle M, Walter J. A home program of rehabilitation for moderately severe traumatic brain injury patients. The DVHIP Study Group. J Head Trauma Rehabil. 2000;15:1092-1102.
6. Walker GC, Cardenas DD, Guthrie MR, McLean A Jr, Brooke MM. Fatigue and depression in brain-injured patients correlated with quadriceps strength and endurance. Arch Phys Med Rehabil. 1991;72:469-472.
7. Belmont A, Agar N, Hugeron C, Gallais B, Azouvi P. Fatigue and traumatic brain injury. Ann Readapt Med Phys. 2006;49(6):283-8, 370-4.
8. van der Naalt J, van Zomeren AH, Sluiter WJ, Minderhoud JM. One year outcome in mild to moderate head injury: the predictive value of acute injury characteristics related to complaints and return to work. J Neurol Neurosurg Psychiatry. 1999;66:207-213.
9. Riese H, Hoedemaeker M, Brouwer W, Mulder LJM, Cremer R, Veldman J. Mental fatigue after very severe closed head injury: sustained performance, mental effort, and distress at two levels of workload in a driving simulator. Neuropsychol Rehabil. 1999;9:189-205.
10. Borgaro SR, Baker J, Wethe JV, Prigatano GP, Kwasnica C. Subjective reports of fatigue during early recovery from traumatic brain injury. J Head Trauma Rehabil 2005;20:(5)416-425.
11. Ziino C, Ponsford J. Measurement and prediction of subjective fatigue following traumatic brain injury. J Int Neuropsychol Soc 2005;11:(4)416-425.
12. Lee KA, Lentz MJ, Taylor DL, Mitchell ES, Woods NF. Fatigue as a response to environmental demands in women's lives. Image J Nurs Sch. 1994;26:149-154.
13. Taylor RR, Jason LA, Torres A. Fatigue rating scales: an empirical comparison. Psychol Med 2000;30:849-856.
14. Okuyama T, Akechi T, Kugaya A, et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, selfrating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 2000;19:5-14.
15. Ziino C, Ponsford J. Vigilance and fatigue following traumatic brain injury. J Int Neuropsychol Soc 2006;12:(1)100-110.
16. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-325.
17. Sullivan S, Richer E, Laurent F. The role of and possibilities for physical condition programmes in the rehabilitation of traumatically brain-injured persons. Brain Inj. 1990;4:407-414.
18. Wolman R, Cornall C, Fulcher MK, Greenwood R. Aerobic training in brain-injured patients. Clin Rehabil. 1994;8:253-257.
19. Jankowski LW, Sullivan SJ. Aerobic and neuromuscular training: effect on the capacity, efficiency, and fatigability of patients with traumatic brain injuries. Arch Phys Med Rehabil. 1990;71:500-504.
20. Ericksen J, Cifu D, Burnett D. The role of neuropharmacologic agents in return to work after traumatic brain injury. Brain Inj Source. Winter 2001;5:32-34.
21. Anonymous. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol. 1998;43:88-97.
22. Anonymous. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurol. 2000;54:1166-1175.
23. Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;164(9):1675-1681.
24. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28:(4)464-471.
25. Czeisler CA, Walsh JK, Roth T, et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl JMed. 2005;353(5):476-486.
26. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22:757-765.
27. Roth T, Roehrs TA. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther 1996;18:562-576; discussion 561.
28. Ouellet MC, Beaulieu-Bonneau S, Morin CM. Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors. J Head Trauma Rehabil. 2006;21(3):199-212.
29. Fichtenberg N, Zafonte R, Putnam, Mann N, Millard A. Insomnia in a post-acute brain injury sample. Brain Inj. 2002;16:197-206.
30. Parcell DL, Ponsford JL, Rajaratnam SM, Redman JR. Self-reported changes to nighttime sleep after traumatic brain injury. Arch Phys Med Rehabil. 2006;87(2):278-285.
31. Beetar JT, Guilmette TJ, Sparadeo FR. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Arch Phys Med Rehabil. 1996;77:1298-1302.
32. Hammond F, Zafonte R. Drugs for management of sleep disorders. Phys Med Rehabil Clin N Am. 1997;8:801-825.
33. Webster JB, Bell KR, Hussey JD, Natale TK, Lakshminarayan S. Sleep apnea in adults with traumatic brain injury: a preliminary investigation. Arch Phys Med Rehabil. 2001;82(3):316-321.
34. Clinchot DM, Bogner J, Mysiw WJ, Fugate L, Corrigan J. Defining sleep disturbance after brain injury. Am J Phys Med Rehabil. 1998;77(4):291-295.
35. Masel BE, Scheibel RS, Kimbark T, Kuna ST. Excessive daytime sleepiness in adults with brain injuries. Arch Phys Med Rehabil. 2001;82:1526-1532.
36. Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol. 2005;20(2):97-104.
37. Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67(4):554-566.
38. Castriotta RJ, Lai JM. Sleep disorders associated with traumatic brain injury. Arch Phys Med Rehabil. 2001;82:1403-1406.
39. Teitelman E. Off-label uses of modafinil. Am J Psychiatry 2001;158:1341.
40. Harrison-Felix C, Newton C, Hall K, Kreutzer J. Descriptive findings from the Traumatic Brain Injury Model Systems National Data Base. J Head Trauma Rehabil. 1996;11:1-14.
41. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-1123.
42. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(suppl 1):79-83.
43. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci. 1993;5:200-205.
44. LaChapelle DL, Finlayson MA. An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain Inj. 1998;12:649-659.
45. Johns M. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
46. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry. 2002;72:179-183.
47. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth Sleepiness Scale: failure of the MSLT as a gold standard. J Sleep Res. 2000;9:5-11.
48. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15:376-381.
49. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
50. Findler M, Cantor J, Haddad L, Gordon W, Ashman T. The reliability and validity of the SF-36 health survey questionnaire for use with individuals with traumatic brain injury. Brain Inj. 2001;15:715-723.
51. Maroon JC, Lovell MR, Norwig J, Podell K, Powell JW, Hartl R. Cerebral concussion in athletes: evaluation and neuropsychological testing. Neurosurgery. 2000;47:659-669; discussion 669-72.
52. Lovell M, Collins M, Fu F, et al. Neuropsychological testing in sports: past, present, and future. Br J Sports Med. 2001;35:367.
53. Lovell M, Collins M, Maroon J, et al. Inaccuracy of symptom reporting following concussion in athletes. Med Sci Sports Exerc. 2002;34:supplement.
54. Collins M, Lovell M, Maroon J, Cantu R, McKeag D. Memory dysfunction eight-days post injury in high school athletes. Med Sci Sports Exerc. 2002;34:supplement.
55. Collins M, Lovell M, Hawn K, et al. Recovery patterns following concussion: implications for return to play. J Athletic Train. 2002;37:supplement.
56. Hawn K, Lovell M, Collins M, et al. Important markers of concussion severity: retrograde and anterograde amnesia. J Athletic Train. 2002;37:supplement.
57. Lovell M, Collins M, Hawn K, et al. Does brief loss of consciousness define concussion severity in athletes? J Athletic Train. 2002;37:supplements.
58. Schatz P, Pardini JE, Lovell MR, Collins MW, Podell K. Sensitivity and specificity of the ImPACT Test Battery for concussion in athletes. Arch Clin Neuropsychol. 2006;21:(1)91-99.
59. Iverson GL, Lovell MR, Collins MW. Validity of ImPACT for measuring processing speed following sports-related concussion. J Clin Exp Neuropsychol. 2005;27:(6)683-689.
60. Iverson GL, Gaetz M, Lovell MR, Collins MW. Relation between subjective fogginess and neuropsychological testing following concussion. J Int Neuropsychol Soc. 2004;10(6):904-906.
61. Conners CK. Conners' CPTII-Continuous Performance Test II. North Tonawanda, NY: Multi-Health Systems Inc; 2000.
62. Homack S, Riccio CA. Conners' Continuous Performance Test (2nd ed.; CCPT-II). J Atten Disord. 2006;9(3):556-558.
63. Beck A. Beck Depression Inventory II. San Antonio, TX: Psychological Corp; 1996.
64. Christensen L, Duncan K. Distinguishing depressed from non-depressed individuals using energy and psychosocial variables. J Consult Clin Psychol. 1995;63:495-498.
65. Green A, Felmingham K, Baguley IJ, Slewa-Younan S, Simpson S. The clinical utility of the Beck Depression Inventory after traumatic brain injury. Brain Inj. 2001;15:1021-1028.
66. Rowland SM, Lam CS, Leahy B. Use of the Beck Depression Inventory-II (BDI-II) with persons with traumatic brain injury: analysis of factorial structure. Brain Inj. 2005;19:(2)77-83.
67. Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology. 2005;64(7):1139-1143.
68. Sevy S, Rosenthal MH, Alvir J, et al. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. J Clin Psychiatry. 2005;66(7):839-843.
69. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry. 2005;76:(12)1636-1639.
70. Chan KM, Strohschein FJ, Rydz D, Allidina A, Shuaib A, Westbury CF. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients. Muscle Nerve. 2006;33(1):138-141.
71. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry. 2005;66(1):85-93.
72. Ninan PT, Hassman HA, Glass SJ, McManus FC. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. J Clin Psychiatry. 2004;65(3):414-420.
73. DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry. 2003;64(9):1057-1064.
74. Carter GT, Han JJ, Mayadev A, Weiss MD. Modafinil reduces fatigue in Charcot-Marie-tooth disease type 1a: a case series. Am J Hosp Palliat Care. 2006;23(5):412-416.
75. Jones DE, Newton JL. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;25(4):471-476.
76. Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol. 2002;249(8):983-987.
77. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology. 2006;44(1):91-98.
78. Smith S, Sullivan KA. A reliable change index (RCI) for the Epworth sleepiness scale (ESS). Sleep Med. 2007 May 17 [Epub ahead of print].